418 related articles for article (PubMed ID: 36741386)
1. Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation.
Roy T; Banang-Mbeumi S; Boateng ST; Ruiz EM; Chamcheu RN; Kang L; King JA; Walker AL; Nagalo BM; Kousoulas KG; Esnault S; Huang S; Chamcheu JC
Front Immunol; 2022; 13():1075804. PubMed ID: 36741386
[TBL] [Abstract][Full Text] [Related]
2. Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models.
Chamcheu JC; Esnault S; Adhami VM; Noll AL; Banang-Mbeumi S; Roy T; Singh SS; Huang S; Kousoulas KG; Mukhtar H
Cells; 2019 Sep; 8(9):. PubMed ID: 31540162
[TBL] [Abstract][Full Text] [Related]
3. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis.
Varshney P; Saini N
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1795-1803. PubMed ID: 29432814
[TBL] [Abstract][Full Text] [Related]
4. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MEG3 suppresses PI3K/AKT/mTOR signalling pathway to enhance autophagy and inhibit inflammation in TNF-α-treated keratinocytes and psoriatic mice.
Tang ZL; Zhang K; Lv SC; Xu GW; Zhang JF; Jia HY
Cytokine; 2021 Dec; 148():155657. PubMed ID: 34425525
[TBL] [Abstract][Full Text] [Related]
6. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
[TBL] [Abstract][Full Text] [Related]
7. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
8. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
9. IL-17A-targeting fenofibrate attenuates inflammation in psoriasis by inducing autophagy.
Park A; Heo TH
Life Sci; 2023 Aug; 326():121755. PubMed ID: 37236601
[TBL] [Abstract][Full Text] [Related]
10. Notch1/Hes1‑PTEN/AKT/IL‑17A feedback loop regulates Th17 cell differentiation in mouse psoriasis‑like skin inflammation.
Lin YW; Li XX; Fu FH; Liu B; Xing X; Qi R; Ma L
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35582997
[TBL] [Abstract][Full Text] [Related]
11. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
Front Immunol; 2021; 12():635076. PubMed ID: 34025642
[TBL] [Abstract][Full Text] [Related]
12. Protein Kinase CK2 Promotes Proliferation, Abnormal Differentiation, and Proinflammatory Cytokine Production of Keratinocytes via Regulation of STAT3 and Akt Pathways in Psoriasis.
Huang W; Zheng X; Huang Q; Weng D; Yao S; Zhou C; Li Q; Hu Y; Xu W; Huang K
Am J Pathol; 2023 May; 193(5):567-578. PubMed ID: 37080661
[TBL] [Abstract][Full Text] [Related]
13. Cornulin Is Induced in Psoriasis Lesions and Promotes Keratinocyte Proliferation via Phosphoinositide 3-Kinase/Akt Pathways.
Li C; Xiao L; Jia J; Li F; Wang X; Duan Q; Jing H; Yang P; Chen C; Wang Q; Liu J; Shao Y; Wang N; Zheng Y
J Invest Dermatol; 2019 Jan; 139(1):71-80. PubMed ID: 30009832
[TBL] [Abstract][Full Text] [Related]
14. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
[TBL] [Abstract][Full Text] [Related]
15. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
[TBL] [Abstract][Full Text] [Related]
16. Worsening of imiquimod-induced psoriasiform inflammation in mice by environmental pollutant, di-(2-ethylhexyl) phthalate through dysregulation in IL-17A and Nrf2/iNOS signaling in peripheral myeloid and CD4 + T cells.
Alfardan AS; Nadeem A; Ahmad SF; Al-Harbi NO; Alqinyah M; Attia SM; Sarawi W; Alanazi AZ; Alhazzani K; Ibrahim KE
Int Immunopharmacol; 2024 Jan; 126():111293. PubMed ID: 38056199
[TBL] [Abstract][Full Text] [Related]
17. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
18. IL-17A-producing T cells exacerbate fine particulate matter-induced lung inflammation and fibrosis by inhibiting PI3K/Akt/mTOR-mediated autophagy.
Cong LH; Li T; Wang H; Wu YN; Wang SP; Zhao YY; Zhang GQ; Duan J
J Cell Mol Med; 2020 Aug; 24(15):8532-8544. PubMed ID: 32643865
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin Alleviates 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Aggravated Dermatitis in Mice with Imiquimod-Induced Psoriasis-Like Dermatitis by Inducing Autophagy.
Kim HR; Kim JC; Kang SY; Kim HO; Park CW; Chung BY
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921372
[TBL] [Abstract][Full Text] [Related]
20. LY294002 ameliorates psoriatic skin inflammation in mice via blocking the Notch1/Hes1-PTEN/AKT/IL-17A feedback loop.
Lin Y; Zhu X; Li Y; Dou Y; Wang J; Qi R; Ma L
Clin Exp Immunol; 2023 Jul; 213(1):114-124. PubMed ID: 36840628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]